JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
American Express
AXP
$204B
| $524M | 0.12% |
6,125,292
-409,076
| -6% | -$47.6M |
2013 Q2
27 quarters
|
|
177
Vertex Pharmaceuticals
VRTX
$128B
| $522M | 0.12% |
2,194,775
-390,614
| -15% | -$89.6M |
2013 Q2
27 quarters
|
|
178
iShares MSCI India ETF
INDA
$5.89B
| $519M | 0.12% |
21,509,371
-2,062,381
| -9% | -$65.9M |
2014 Q4
21 quarters
|
|
179
MarketAxess Holdings
MKTX
$5.78B
| $519M | 0.12% |
1,559,329
+272,647
| +21% | +$95M |
2015 Q1
20 quarters
|
|
180
Vanguard Real Estate ETF
VNQ
$35.4B
| $518M | 0.12% |
7,414,542
+207,869
| +3% | +$18.3M |
2013 Q2
27 quarters
|
|
|
PXD
181
DELISTED
Pioneer Natural Resource Co.
PXD
| $512M | 0.12% |
7,302,483
+900,499
| +14% | +$107M |
2013 Q2
27 quarters
|
|
182
iShares Core MSCI Europe ETF
IEUR
$8.98B
| $504M | 0.12% |
13,598,229
+1,045,104
| +8% | +$47.1M |
2017 Q1
12 quarters
|
|
183
Broadcom
AVGO
$1.7T
| $503M | 0.12% |
21,223,380
-3,024,850
| -12% | -$85.2M |
2013 Q2
27 quarters
|
|
184
Infosys
INFY
$44.7B
| $503M | 0.12% |
61,284,825
+4,411,736
| +8% | +$44.4M |
2013 Q2
27 quarters
|
|
185
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $501M | 0.12% |
5,185,147
+5,088,698
| +5,276% | +$561M |
2013 Q2
27 quarters
|
|
186
Credicorp
BAP
$29.6B
| $501M | 0.12% |
3,502,341
+297,946
| +9% | +$56.3M |
2013 Q2
27 quarters
|
|
187
Teladoc Health
TDOC
$1B
| $489M | 0.11% |
3,154,743
-1,895,455
| -38% | -$221M |
2015 Q3
18 quarters
|
|
188
Booz Allen Hamilton
BAH
$8.1B
| $489M | 0.11% |
7,124,091
+2,258,824
| +46% | +$166M |
2013 Q2
27 quarters
|
|
|
FRC
189
DELISTED
First Republic Bank
FRC
| $484M | 0.11% |
5,881,160
+474,941
| +9% | +$50.3M |
2013 Q2
27 quarters
|
|
190
iShares Core MSCI Emerging Markets ETF
IEMG
$163B
| $481M | 0.11% |
11,890,939
+1,813,756
| +18% | +$89.1M |
2014 Q1
24 quarters
|
|
191
iShares TIPS Bond ETF
TIP
$14.4B
| $481M | 0.11% |
4,076,347
-2,894,546
| -42% | -$341M |
2013 Q2
27 quarters
|
|
192
Vanguard Information Technology ETF
VGT
$157B
| $471M | 0.11% |
17,767,048
-474,832
| -3% | -$14.4M |
2014 Q2
23 quarters
|
|
193
Las Vegas Sands
LVS
$23.5B
| $467M | 0.11% |
10,994,299
+315,335
| +3% | +$19.1M |
2013 Q2
27 quarters
|
|
194
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.6B
| $465M | 0.11% |
22,340,800
-353,100
| -2% | -$9.72M |
2016 Q4
13 quarters
|
|
195
Ventas
VTR
$43.1B
| $463M | 0.11% |
17,261,708
-1,275,371
| -7% | -$63.3M |
2013 Q2
27 quarters
|
|
196
Biogen
BIIB
$32.5B
| $461M | 0.11% |
1,456,795
+16,971
| +1% | +$5.15M |
2013 Q2
27 quarters
|
|
197
Digital Realty Trust
DLR
$66.2B
| $452M | 0.11% |
3,250,593
+923,746
| +40% | +$117M |
2013 Q2
27 quarters
|
|
198
CBRE Group
CBRE
$37.5B
| $451M | 0.11% |
11,969,707
-249,594
| -2% | -$13.8M |
2013 Q2
27 quarters
|
|
|
AMJ
199
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $451M | 0.11% |
49,908,324
+16,181,887
| +48% | +$283M |
2013 Q2
27 quarters
|
|
200
PPG Industries
PPG
$23.4B
| $450M | 0.11% |
5,377,333
+143,881
| +3% | +$16M |
2013 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.